For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Koji Ogawa, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
https://www.daiichisankyo.com
Daiichi Sankyo Appoints New Group Corporate Officers
TOKYO, Japan (February 22, 2019) – Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2019.
1. DAIICHI SANKYO CO., LTD.
|
Name
|
Current Responsibilities
|
New Responsibilities
|
|
Katsumi Fujimoto
|
Member of the Board
Senior Executive Officer
Head of Supply Chain Div.
|
Member of the Board
|
|
Toshiaki Tojo
|
Member of the Board
Senior Executive Officer
In charge of Vaccine Business
|
Member of the Board
Senior Executive Officer
In charge of Vaccine Business
and Quality & Safety Management
|
|
Junichi Koga
|
Senior Executive Officer
Head of R&D Div.
|
Senior Executive Officer
Global Head of R&D
|
|
Masahiko Ohtsuki
|
Corporate Officer
Vice President of Business
Development & Licensing Dept.
|
Executive Officer
Vice President of Business
Development & Licensing Dept.
|
|
Junichi Fukute
|
Corporate Officer
Vice President of Supply Chain
Planning Dept., Supply Chain Div.
|
Executive Officer
Head of Supply Chain Div.
|
|
Takeshi Hamaura
|
Corporate Officer
Head of Pharmaceutical Technology Div.
|
Executive Officer
Head of Pharmaceutical Technology Div.
|
|
Shoji Hirashima
|
Corporate Officer
Vice President of Corporate
Business Management Dept.,
Corporate Strategy & Management Div.
|
Executive Officer
Head of Global Brand Strategy Div.
|
|
Ryoichi Watanabe
|
Corporate Officer
Vice President of Internal Audit Dept.
|
Corporate Officer
In charge of Internal Audit Dept.
|
|
Hironobu Furuta
|
Corporate Officer
Vice President of Human Resources
Dept., Corporate Affairs Div.
|
Corporate Officer
Head of Corporate Affairs Div.
|
|
Koji Ogawa
|
Corporate Officer
Vice President of Corporate
Communications Dept., Corporate
Strategy & Management Div.
|
Corporate Officer
Head of US Corporate Div.,
Daiichi Sankyo, Inc.
|
|
Seiichiro Kumakura
|
Vice President of Research Function,
R&D Div.
|
Corporate Officer
Vice President of Research Function,
R&D Div.
|
|
Takashi Fukuoka
|
Vice President of Venture Science
Laboratories, R&D Div.
|
Corporate Officer
Executive Vice President, R&D Affairs,
Daiichi Sankyo, Inc.
|
|
Hironobu Saito
|
Vice President of Oncology Clinical
Development Dept., Oncology Function,
R&D Div.
|
Corporate Officer
Vice President of Oncology Clinical
Development Dept., Oncology Function,
R&D Div.
|
|
Wataru Takasaki
|
Vice President of R&D Planning &
Management Dept., R&D Div.
|
Corporate Officer
Head of R&D Div. and Vice President
of Oncology Function
|
|
Tomoji Hashiba
|
Vice President of Tohoku Branch,
Sales & Marketing Div.
|
Corporate Officer
Vice President of Kyushu Branch,
Sales & Marketing Div.
|
|
Miyuki Arai
|
Vice President of Safety and Risk
Management Dept., Quality & Safety
Management Div.
|
Corporate Officer
Head of Quality & Safety Management
Div.
|
◇Glenn Gormley (current Senior Executive Officer) will continue to serve as Executive Chairman of the Board of Daiichi Sankyo, Inc.
◇Koichi Akahane, Yoshihiro Aoyagi, Yuichi Kubo and Kohei Wada (current Executive Officer) will be appointed Corporate Advisor as of April 1st, 2019.
◇Kenji Katsumi (current Corporate Officer) will be appointed the President of Daiichi Sankyo Business Associe Co., Ltd. as of April 1st, 2019.
◇Kentaro Murakawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Espha Co., Ltd. as of April 1st, 2019.
◇Hirosumi Izawa (current Corporate Officer) will be appointed the President of Daiichi Sankyo Propharma Co., Ltd. as of April 1st, 2019.
2. DAIICHI SANKYO ESPHA CO., LTD.
|
Name
|
Current Responsibilities
|
New Responsibilities
|
|
Kentaro Murakawa
|
Corporate Officer
Vice President of Sales Planning Dept.
and Senior Director of
Sales Management Group,
Sales & Marketing Div.,
DAIICHI SANKYO CO., LTD.
|
President
|
|
Ichiro Ishizuka
|
Member of the Board
Head of Sales & Marketing Div.
|
Executive Vice President
Head of Sales & Marketing Div.
|
|
Hiroto Yoshiwaka
|
President
|
Member of the Board
|
|
Takeshi Shinseki
|
Member of the Board
In charge of Corporate Strategy and
Vice President of Corporate Business
Management Dept.
|
Member of the Board
Head of Corporate Strategy &
Management Div.
|
|
Kosuke Natori
|
Vice President of Corporate Strategy Dept.
|
Member of the Board
Vice President of Corporate Business
Management Dept., Corporate
Strategy & Management Div.
|
3. DAIICHI SANKYO HEALTHCARE CO., LTD.
|
Name
|
Current Responsibilities
|
New Responsibilities
|
|
Yoshiki Nishii
|
President
|
Chairman
|
|
Katsuhiko Yoshida
|
Member of the Board
Senior Executive Officer
In charge of Corporate Administration
and Vice president of Corporate
Planning Dept.
|
President
|
|
Yasuhiro Kawanaka
|
Member of the Board
Executive Officer
Vice President of Sales Administration Div.
|
Member of the Board
|
|
Masatoshi Yamamoto
|
Corporate Officer
Vice President of Quality and Safety
Management Dept.
|
Member of the Board
Corporate Officer
Vice President of Quality and Safety
Management Dept.
|
|
Tomohiko Yamaguchi
|
Corporate Officer
Vice President of R&D Dept.
|
Member of the Board
Corporate Officer
Vice President of R&D Dept.
|